TY - JOUR

T1 - Worsening of chronic heart failure

T2 - definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology

AU - Metra, Marco

AU - Tomasoni, Daniela

AU - Adamo, Marianna

AU - Bayes-Genis, Antoni

AU - Filippatos, Gerasimos

AU - Abdelhamid, Magdy

AU - Adamopoulos, Stamatis

AU - Anker, Stefan D.

AU - Antohi, Laura

AU - Böhm, Michael

AU - Braunschweig, Frieder

AU - Gal, Tuvia Ben

AU - Butler, Javed

AU - Cleland, John G.F.

AU - Cohen-Solal, Alain

AU - Damman, Kevin

AU - Gustafsson, Finn

AU - Hill, Loreena

AU - Jankowska, Ewa A.

AU - Lainscak, Mitja

AU - Lund, Lars H.

AU - McDonagh, Theresa

AU - Mebazaa, Alexandre

AU - Moura, Brenda

AU - Mullens, Wilfried

AU - Piepoli, Massimo

AU - Ponikowski, Piotr

AU - Rakisheva, Amina

AU - Ristic, Arsen

AU - Savarese, Gianluigi

AU - Seferovic, Petar

AU - Sharma, Rajan

AU - Tocchetti, Carlo Gabriele

AU - Yilmaz, Mehmet Birhan

AU - Vitale, Cristiana

AU - Volterrani, Maurizio

AU - von Haehling, Stephan

AU - Chioncel, Ovidiu

AU - Coats, Andrew J.S.

AU - Rosano, Giuseppe

N1 - Publisher Copyright: © 2023 European Society of Cardiology.

PY - 2023

Y1 - 2023

N2 - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.

AB - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.

KW - Emergency department visits

KW - Hospitalization

KW - Intensification of oral therapy

KW - Outpatients

KW - Prognosis

KW - Worsening heart failure

U2 - 10.1002/ejhf.2874

DO - 10.1002/ejhf.2874

M3 - Journal article

C2 - 37208936

AN - SCOPUS:85159710877

VL - 25

SP - 776

EP - 791

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1567-4215

IS - 6

ER -